Icatibant Acetate
CAS No. 138614-30-9
Icatibant Acetate ( —— )
产品货号. M23545 CAS No. 138614-30-9
Icatibant Acetate 是一种缓激肽 B2 受体拮抗剂,用于治疗遗传性血管性水肿。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥794 | 有现货 |
|
| 5MG | ¥1596 | 有现货 |
|
| 10MG | ¥2535 | 有现货 |
|
| 25MG | ¥4277 | 有现货 |
|
| 50MG | ¥6099 | 有现货 |
|
| 100MG | ¥7995 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Icatibant Acetate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Icatibant Acetate 是一种缓激肽 B2 受体拮抗剂,用于治疗遗传性血管性水肿。
-
产品描述Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema.
-
体外实验——
-
体内实验Animal Model:Female mice of the CBA/J (H-2k) strain.Dosage:0.06, 0.3, or 1.5 mg/kg.Administration:Subcutaneous administration twice daily.Result:The length of the large intestine was 93.6±6.8 mm with the 1.5 mg/kg dosage and 94.0±4.1 mm with the 0.3 mg/kg dosage , showing a significant preventive effect on shortening.
-
同义词——
-
通路GPCR/G Protein
-
靶点Bradykinin Receptor
-
受体bradykinin B2
-
研究领域——
-
适应症——
化学信息
-
CAS Number138614-30-9
-
分子量1364.57
-
分子式C61H93N19O15S
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL?(73.28 mM;?Need ultrasonic)
-
SMILESCC(=O)O.N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](Cc3cccs3)C(=O)N[C@@H](CO)C(=O)N4Cc5ccccc5C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Sar-[D-Phe8]-des-Arg...
Potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic activity in vivo.
-
Bradykinin (1-5)
Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).The bradykinin (BK) fragment (1-5) (RPPGF) is among the most stable of naturally occurring metabolites. Bradykinin (1-5) may be used as a marker for BK production in vivo.
-
MEN 11270
Peptide antagonist of the B2 bradykinin receptor (pKi = 10.3); conformationally constrained cyclized analog of HOE 140. Blocks hypotension and bronchoconstriction in vivo. Displays selectivity for B2 over 29 other receptors and ion channels (pIC50 < 5.5).
021-51111890
购物车()
sales@molnova.cn

